Alice Han

InstitutionMetro Infectious Disease Consultants
AddressChicago
Illinois
United States
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 3 Covid-19 publications, with a maximum of 1 publications in January 2021 and March 2021 and October 2021
    All Publications
    Bar chart showing 12 publications over 8 distinct years, with a maximum of 3 publications in 2021
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Petrak RM, Skorodin NC, Van Hise NW, Fliegelman RM, Pinsky J, Didwania V, Anderson M, Diaz M, Shah K, Chundi VV, Hines DW, Harting BP, Sidwha K, Yu B, Brune P, Owaisi A, Beezhold D, Kent J, Vais D, Han A, Gowda N, Sahgal N, Silverman J, Stake J, Nepomuceno J, Heddurshetti R. Tocilizumab as a Therapeutic Agent for Critically Ill Patients Infected with SARS-CoV-2. Clin Transl Sci. 2021 11; 14(6):2146-2151. PMID: 32918792.
      Citations: 9     Fields:    Translation:Humans
    2. Petrak RM, Van Hise NW, Skorodin NC, Fliegelman RM, Chundi V, Didwania V, Han A, Harting BP, Hines DW. Early Tocilizumab Dosing Is Associated With Improved Survival in Critically Ill Patients Infected With Severe Acute Respiratory Syndrome Coronavirus-2. Crit Care Explor. 2021 Apr; 3(4):e0395. PMID: 33817660.
      Citations: 3     
    3. Han A, Rodriguez TE, Beck ET, Relich RF, Udeoji DU, Petrak R, Chundi VV. Persistent SARS-CoV-2 infectivity greater than 50 days in a case series of allogeneic peripheral blood stem cell transplant recipients. Curr Probl Cancer Case Rep. 2021 Mar; 3:100057. PMID: 34308401.
      Citations: 2